Follow the NeuPath Health Inc. share price and the full management transaction log of the company, a listed issuer based in Canada. Shares are listed on the CA market, under the authority of SEDI. Market capitalisation: €31.3m. The latest transaction was reported on 28 August 2026 (38 - Redemption, retraction, cancellation, repurchase). Among the most active insiders: NeuPath Health Inc.. Every trade is free.
47
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate NeuPath Health Inc. Strong Buy (bullish), based on 2 analysts. Average price target: CA$0.77.
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,917 of 29,063 companies
39.5
score / 100
Value
48
Quality
31
FCF yld9.8%
Earn yld-2.2%
EV/EBITDA14.4x
ROE7.2%
Gross mgn19%
Net mgn-0.8%
Debt/EBITDA4.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
7,500 shares@ CA$0.590.014% mcap6.5% of flowCommon SharesTSXSEDI:4743633
25 of 47 declarations
Acerca de NeuPath Health Inc.
NeuPath Health Inc. es una empresa canadiense de atención médica centrada en el tratamiento del dolor crónico. Opera principalmente en la Bolsa de Valores de Toronto (XTSE).